Editorial
Free Access
Eosinophils and primary biliary cirrhosis—Stoking the fire?
James Neuberger M.D.,
Corresponding Author
James Neuberger M.D.
M.D.
From the Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
The Liver and Hepatobiliary Unit, 3rd Floor, Nuffield House, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, fax: (44) 121 627 2449===Search for more papers by this authorJames Neuberger M.D.,
Corresponding Author
James Neuberger M.D.
M.D.
From the Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
The Liver and Hepatobiliary Unit, 3rd Floor, Nuffield House, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, fax: (44) 121 627 2449===Search for more papers by this author
References
- 1 Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996; 98: 371–381. MEDLINE
- 2 Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Res 1986; 85: 422–456.
- 3 Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophil-fibroblast interactions. J Immunol 1996; 156: 4449–4456. MEDLINE
- 4 Kokubin M, Kuroda M, Takagi T, Saito K, Nishimaki T, Morito T, Kasukawa R. Eosinophilia in primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi 1990; 87: 1410–1416. MEDLINE
- 5 Wirth HP, Meyenberger C, Altorfer J, Ammann R, Blum HE. Eosinphilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid. Schweiz Med Wochenschr 1994; 124: 810–815. MEDLINE
- 6 Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91: 516–522. MEDLINE
- 7 Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinphilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 1993; 17: 206–212. MEDLINE
- 8 Nakamura A, Yamazaki K, Suzuki K, Sato S. Increased portal tract infiltrate of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 1997; 92: 2245–2249. MEDLINE
- 9 Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5 and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996; 80: 311–320. MEDLINE
- 10 Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 723–733. MEDLINE
- 11 Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113–119. MEDLINE
- 12 Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25: 791–796. MEDLINE
- 13 Shindo M, Mullin GE, Braun-Elert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996; 105: 254–259. MEDLINE
- 14 Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, Meyer zum Buschenfelde KH. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431: 119–124. MEDLINE
- 15 Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 115–123. MEDLINE
- 16 Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998; 161: 4340–4346. MEDLINE
- 17 Ohashi H, Takei M, Ide Y, Ishii H, Kita H, Gleich GJ, Ishikawa M, et al. Effect of interleukin-3, interleukin 5 and hyaluronic acid on cultured eosinophils derived from human umbilical cord blood mononuclear cells. Int Arch Allergy Immunol 1999; 118: 44–50. MEDLINE
- 18 Gharib B, Abdallahi OM, Dessein H, de Reggi M. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice affected with Schistosoma mansoni. J Hepatol 1999; 30: 594–602. MEDLINE
- 19 Goulis J, Leandro G, Burroughs AK. No evidence for ursodeoxycholic (UDCA) therapy in primary biliary cirrhosis (PBC): a meta-analysis [Abstract]. J Hepatol 1999; 30(Suppl 1): 57.
- 20 Gluud C, Christensen E. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)—a Cochrane hepatobiliary systematic review [Abstract]. J Hepatol 1999; 30(Suppl 1): 83.
- 21 Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875–879. MEDLINE
- 22 Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, Tarara JE, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999; 30: 71–78. MEDLINE
- 23 Stiehl A, Benz C, Sauer P. Mechanism of hepatoprotective action of bile salts in liver disease. Gastroenterol Clinics North Am 1999; 28: 195–209.
- 24 Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, et al. Immunomodulatory effects of ursodeoxycholic acid on immune resposes. Hepatology 1992; 16: 358–364. MEDLINE
- 25 Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 1992; 103: 617–621. MEDLINE
- 26 Calmus Y, Podevin P, Robert A, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on expression of procoagulant activity by human monocytes. J Hepatol 1994; 20: 466–472. MEDLINE
- 27 Hattori Y, Murakami Y, Hattori S, Kuroda H, Kasai K, Shimoda S. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. Eur J Pharmacol 1996; 300: 147–150. MEDLINE
- 28 Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998; 352: 1595–1596. MEDLINE
- 29 Sanders SP. Asthma, viruses and nitric oxide. Proc Soc Exp Biol Med 1999; 220: 123–132. MEDLINE
- 30 Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology 1991; 101: 446–456. MEDLINE
- 31 Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993; 18: 165–172. MEDLINE
- 32 Nishigaki Y, Ohnishi H, Moriwaki H, Muto Y. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. Dig Dis Sci 1996; 41: 1487–1493. MEDLINE
- 33 Bergamini A, Dini L, Baiocchi L, Cappannoli L, Falasca L, Bolacchi F, Capozza M, et al. Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology 1997; 25: 927–933. MEDLINE
- 34 Khan KN, Tsutumi T, Nakata K, Nakao K, Kato Y, Nagataki S. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids. J Gastroenterol Hepatol 1998; 13: 643–650. MEDLINE
- 35 Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullal-Ublick GA, Sauter G, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996; 110: 1553–1563. MEDLINE
- 36 Matsuzaki Y, Bouscarel B, Le M, Ceryak S, Gettys TW, Shoda J, Fromm H. Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes. Am J Physiol 1997; 273: G164–G174. MEDLINE
- 37 Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leucocytes. J Immunol 1999; 162: 3639–3646. MEDLINE
- 38 Matsukura M, Yamada H, Yudate T, Tezuka T, Chihara J. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients. J Clin Lab Immunol 1996; 48: 109–122. MEDLINE
- 39 Mitchison HC, Palmer JM, Bassendine M, Watson AJ, Record CO, James OFW. A controlled trial of prednisolone treatment in primary biliary cirrhosis. J Hepatol 1992; 15: 336–344. MEDLINE
- 40 Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, et al. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. J Immunol 1996; 156: 1601–1608. MEDLINE
- 41 Meng Q, Ying S, Corrigan CJ, Wakelin M, Assoufi B, Moqbel R, Kay AB. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy 1997; 52: 1095–1101. MEDLINE
- 42 Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring Larsen H, et al. Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993; 104: 519–526. MEDLINE
- 43 Miyaguchi S, Oda M, Saito H, Ishii H. Novel therapeutic approach to primary biliary cirrhosis: anti-eosinophil strategy. Hepatogastroenterology 1998; 45: 1457–1461. MEDLINE
- 44 Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K. Fourteen member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother 1999; 43: 907–911. MEDLINE
